MedPath
HSA Approval

INDRONATE FILM-COATED TABLET 35 MG

SIN14439P

INDRONATE FILM-COATED TABLET 35 MG

INDRONATE FILM-COATED TABLET 35 MG

November 14, 2013

INTEGA PTE LTD

INTEGA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantINTEGA PTE LTD
Licence HolderINTEGA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M05BA07

risedronic acid

Manufacturer Information

INTEGA PTE. LTD.

Pharmathen S.A.

Pharmathen International S.A.

Active Ingredients

Risedronate sodium hemipentahydrate 40.17mg equiv. to Risedronate sodium

35mg

Risedronic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

INDRONATE FILM-COATED TABLET 35 MG - HSA Approval | MedPath